This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Elanco expects Bayer Animal Health deal to close mid-2020, CEO says

( May 7, 2020, 12:16 GMT | Official Statement) -- MLex Summary: Elanco Animal Health's chief executive said its acquisition of Bayer Animal Health continues to advance and it expects the deal to close by the middle of this year. "We remain encouraged by the regulatory and integration planning progress despite Covid-19 challenges, as well as Bayer's strong financial performance in the first quarter. We continue to look toward a mid-2020 close," Jeff Simmons said in a press release.Excerpt follows....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login